Amlodipine Besylate And Benazepril Hydrochloride Capsule
Product Images NDC 71335-1946

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Benazepril Hydrochloride (NDC 71335-1946). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (55323c6b 4efc 466a 82ff 7a5d66b77c2d 01)

HCI stands for Human-Computer Interaction. This field focuses on the design, development, and evaluation of interactive computing systems for human use. It involves various disciplines such as computer science, psychology, anthropology, design, and engineering to ensure that technology is usable, accessible, and efficient for its intended users. The main goal of HCI is to improve the experiences that people have with computer systems by creating user-friendly interfaces and enhancing user engagement.*

FDA Label Image

Image (55323c6b 4efc 466a 82ff 7a5d66b77c2d 02)

FDA Label Image

Label (Lbl713351946)

This appears to be a medication label. The medication is a combination of Amlodipine Besylate and Benazepril HCI in a pink capsule with the imprint "LU;E13". It should be stored at room temperature between 20°-25°C (68°-77°F). The medication is packaged in a bottle containing 30 capsules, with an expiration date of MM/YY. The National Drug Code (NDC) is 7133519461 and 01454301523487.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.